Search

Your search keyword '"Bouvy, M.L."' showing total 594 results
Start Over Author "Bouvy, M.L."
594 results on '"Bouvy, M.L."'

5. Necessary patient data for community pharmacists to assess DOAC prescriptions

Author

Weele, Carien van der, Bouvy, M.L. (Thesis Advisor), Weele, Carien van der, and Bouvy, M.L. (Thesis Advisor)

Abstract

Introduction: The number of DOAC users is increasing. Prescriptions of DOACs are not always accurate due to prescribing errors, especially in the presence of risk factors. Pharmacists play an important role in detecting and correcting incorrect prescriptions, but they need clinical patient data to do so. Unfortunately, these are not always known. In this study, we want to understand what clinical data are missing on first prescriptions of DOACs, what data pharmacists consider necessary, and what barriers, facilitators and opportunities they see with regard to data availability. Method: This research is a combination of qualitative and quantitative research. 18 pharmacies from the Utrecht region participated and 10 pharmacists were interviewed. Data was collected from the first prescriptions of DOACs by means of registration forms. This could indicate, among other things, what was missing and what information had been requested. The interviews asked about barriers, facilitators and opportunities for data availability and the reason for requesting data was requested. Results: Renal function and indication were retrieved significantly more often if they were missing (P < 0.001; P = 0.001). For prescriptions from the hospital, the data was less often missing than when these came from the GP. The main reason for requesting data was dose control. The main facilitator were the systems for communication, monitoring and sending lab values. The biggest barrier was the poor accessibility of the prescribers. An opportunity was mentioned to improve systems so that they automatically send all the necessary data as soon as it is prescribed. Conclusion: Pharmacists consider it important to have an indication and renal function on a prescription. Duration of use, combination therapy and weight were known less often, possibly because they could be deduced by clinical reasoning. Pharmacists find systems that share data helpful, but would also like to improve them by automatically link

Published
2024

6. Cognitive processes in pharmacists’ clinical decision-making

Author

Afd Pharmacoepi & Clinical Pharmacology, PECP – Centre for Clinical Therapeutics, Pharmacoepidemiology and Clinical Pharmacology, Mertens, J.F., Kempen, T.G.H., Koster, E.S., Deneer, V.H.M., Bouvy, M.L., van Gelder, T., Afd Pharmacoepi & Clinical Pharmacology, PECP – Centre for Clinical Therapeutics, Pharmacoepidemiology and Clinical Pharmacology, Mertens, J.F., Kempen, T.G.H., Koster, E.S., Deneer, V.H.M., Bouvy, M.L., and van Gelder, T.

Published
2024

7. Measures taken in primary healthcare to reduce inappropriate opioid use and the opioid prescribing behavior of general practitioners: a baseline measurement

Author

Chams, Ikrame, Bouvy, M.L. (Thesis Advisor), Chams, Ikrame, and Bouvy, M.L. (Thesis Advisor)

Abstract

Objective: In the past two decades, opioid use has increased in the Netherlands. Inappropriate use of opioids can lead to dependency, addiction, and abuse. To reduce inappropriate opioid use, the Tool for Reducing Inappropriate Opioid use for Physicians, Pharmacists, and Patients (TRIO-3P) developed a tool. The aim of this research project was to examine the baseline situation of the measures taken by general practitioners and pharmacists prior to TRIO-3P-study participation to reduce inappropriate opioid use, the baseline situation of the prescribing behavior of general practitioners and whether there is a correlation between the taken measures and the prescribing behavior. Methods: We developed questionnaires in Castor EDC for general practitioners and pharmacists about the measures taken prior to study participation to reduce inappropriate opioid use and analyzed these questionnaires using SPSS. Prescription data of the included general practitioners were extracted, analyzed, and compared to the mean number of users of strong-acting opioids and the mean number of patients with long term opioid treatment by using independent samples T-tests through SPSS. Results: 37 general practitioners and 22 pharmacists were included. The questionnaires showed that a small proportion of the general practitioners and pharmacists took measures prior to study participation to reduce inappropriate opioid use. Prescription data vary widely between general practitioners. Oxycodone was the most prescribed strong-acting opioid. No significant correlations were seen between the measures taken prior to study participation and the prescription data. Conclusion: Few GPs and pharmacists took measures to reduce inappropriate opioid use prior to TRIO-3P-study participation. TRIO-3P intervention components may give handholds to general practitioners and pharmacists to reduce inappropriate opioid use.

Published
2024

10. 39 Geneesmiddelen die de stoelgang beïnvloeden

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

11. 40 Dermatologische preparaten

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

12. 38 Geneesmiddelen bij maag-darmaandoeningen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

13. 37 Geneesmiddelen bij luchtwegaandoeningen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

14. 35 Geneesmiddelen die de bloedstolling beïnvloeden

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

15. 36 Geneesmiddelen bij atherosclerose en andere doorbloedingsstoornissen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

16. 34 Antihypertensiva

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

17. 33 Diuretica

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

18. 31 Geneesmiddelen bij decompensatio cordis

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

19. 30 Geneesmiddelen bij angina pectoris

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

20. 17 Analgetica

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

21. 8 Antibiotica

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

22. 28 Het autonome zenuwstelsel

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

23. 25 Geslachtshormonen en anticonceptiva

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

24. 26 Insuline en diabetes mellitus

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

25. 9 Geneesmiddelen bij tuberculose

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

26. 24 Corticosteroïden

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

27. 23 Hypofyse- en hypothalamushormonen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

28. 22 Antiparkinsongeneesmiddelen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

29. 20 Psychofarmaca

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

30. 19 Hypnotica

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

31. 43 Oncolytica

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

32. 16 Antimicrobiële profylaxe

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

33. 12 Geneesmiddelen bij verkoudheid

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

34. 44 Immunomodulantia

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

35. 7 Fouten bij de geneesmiddelentoediening

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

36. 10 Antivirale middelen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

37. 45 Geneesmiddelen bij intoxicaties

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

38. 2 Geneesmiddelvormen en hun toediening

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

39. 5 Interacties tussen geneesmiddelen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

40. 6 Geneesmiddelen tijdens zwangerschap en borstvoeding

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

41. 4 Farmacokinetiek

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

42. 3 Een juridische blik op geneesmiddelen

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

43. 1 De ontwikkeling van een geneesmiddel

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

44. 21 Anti-epileptica

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

45. 29 Geneesmiddelen die het RAAS beïnvloeden

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

46. 27 Orale antidiabetica

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

47. 11 Geneesmiddelen bij griep

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

48. 15 Sera en vaccins

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

49. 42 Geneesmiddelen bij shock

Author

Bütterhoff, J.J.F., van Opdorp, F.A.C., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bouvy, M.L., Dessing, W.S., van de Garde, E.M.W., Gerbranda, T., Harmsze, A.M., van der Kuy, P.H.M., Nooij, A., Simons-Sanders, K.A., Stolk, P., Takx-Köhlen, B.C.M.J., Zwaan, T., Bütterhoff, J.J.F., editor, and van Opdorp, F.A.C., editor

Published
2016
Full Text
View/download PDF

50. Patients' perspectives on the development of prescription opioid use disorder in patients with chronic non-cancer pain

Author

Davies, L.E.M., Koster, E.S., Damen, K.F.M., Beurmanjer, H., Schellekens, A.F.A., Bouvy, M.L., Davies, L.E.M., Koster, E.S., Damen, K.F.M., Beurmanjer, H., Schellekens, A.F.A., and Bouvy, M.L.

Abstract

14 april 2023, Item does not contain fulltext, Introduction: In the past decade, prescription opioid use increased exponentially and concomitantly opioid use disorders (OUD) are becoming more common. Several risk factors for developing OUD have been identified, but little is known regarding the patients’ perspective on developing a prescription OUD. Methods: We recruited 25 adults undergoing treatment for prescription OUD. In-depth, semi-structured interviews focussed on experiences with long-term opioid use, knowledge and attitudes regarding opioids, and access to opioids. A directed content analysis was conducted on the transcribed interviews using NVivo. Results: Participants showed that the development of an OUD is affected by various factors which could be grouped into three themes: (1) experiences driving initiation, (2) experiences driving continuation, and (3) experiences with prescription OUD. Besides the need for pain management, the dynamics of patient-provider communication, care coordination, provider vigilance, and environmental support all contributed to the way patients used their opioids. Conclusion: Patients' experiences illustrate that the first stage of the development of prescription OUD differs from the development of other substance addictions. Negative reinforcement might play a more prominent role in the early phase of prescription opioid use. Patients expressed a lack of guidance, both at the start of use and long-term use, easy access to new prescriptions and a lack of monitoring as main drivers of the development. Poorly controlled pain and subjective stress fuelled continuous opioid use.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results